Eurofins Biomnis
Driving innovation in specialized medical biology
Diagnostic aids
All contents
June 2023
Infectiology: Diagnosis of Helicobacter pylori
In 1875, German scientists discovered a helical bacterium in human stomachs. In 1982, two Australian researchers, J. R. Warren (pathologist) and B. J. Marshall (gastroenterologist) rediscovered this bacterium among the microorganisms cultivated from human stomach…
May 2023
Tick-borne disease: Babesiosis
Babesiosis is an infection caused by the protozoan Babesia spp. It is often asymptomatic in immunocompetent individuals or results in a malaria-like illness with a fever and haemolytic anaemia, but can be severe in splenectomised…
News and Events
All news
Register now so you don't miss any invitations!
Register
À propos de Biomnis
[Partnership] For personalised treatment in oncology
A Word from our experts
Biological management of of hematological malignancies
Find our documents and information sheets
Find the documents (order form, clinical information sheet ...) available to you for a good management of the requested analysis
Sample calendar - Serum screening for Down’s syndrome in the 1st or 2nd trimester of pregnancy (D21-INTGB-2023)
Diagnostics of mycobacterial infections (DS1-INTGB)
Autoantibodies in the diagnosis and follow-up of auto-immune diseases (DS4-INTGB)
B39-INTGB - Detection of chromosomal abnormalities by analysis of circulating cell-free DNA (NIPT)
Chronic Myelomonocytic Leukemia (CMML) (DS71-INTGB)
Panel sheet
Press Kit 2021
Press area
All press releaseInternational presence
- Implantations Eurofins Biomnis
- Eurofins Biomnis Ireland & UK
- Correspondants Eurofins Biomnis
Eurofins Biomnis is present in many countries
Eurofins Biomnis serves hospitals, medical centres, public and private laboratories, pharmaceutical companies and clinical trial centres on a global scale and is particularly well established in the Middle-East, Europe and Asia.
contact us